rdf:type |
|
lifeskim:mentions |
umls-concept:C0064870,
umls-concept:C0085173,
umls-concept:C0087111,
umls-concept:C0199176,
umls-concept:C0205531,
umls-concept:C0226896,
umls-concept:C0332237,
umls-concept:C0442027,
umls-concept:C1521801,
umls-concept:C1522168,
umls-concept:C1527415,
umls-concept:C1707455
|
pubmed:issue |
1 Pt 1
|
pubmed:dateCreated |
1993-8-25
|
pubmed:abstractText |
This study was designed to compare the efficacy and tolerability of a new topical (nasal spray and eye drops) H1-receptor antagonist, levocabastine, with that of orally administered terfenadine for the prophylaxis and treatment of seasonal allergic rhinoconjunctivitis.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0091-6749
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
92
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
73-81
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8101534-Administration, Oral,
pubmed-meshheading:8101534-Adult,
pubmed-meshheading:8101534-Aerosols,
pubmed-meshheading:8101534-Conjunctivitis, Allergic,
pubmed-meshheading:8101534-Double-Blind Method,
pubmed-meshheading:8101534-Drug Tolerance,
pubmed-meshheading:8101534-Female,
pubmed-meshheading:8101534-Histamine H1 Antagonists,
pubmed-meshheading:8101534-Humans,
pubmed-meshheading:8101534-Male,
pubmed-meshheading:8101534-Norway,
pubmed-meshheading:8101534-Ophthalmic Solutions,
pubmed-meshheading:8101534-Piperidines,
pubmed-meshheading:8101534-Remission Induction,
pubmed-meshheading:8101534-Rhinitis, Allergic, Seasonal,
pubmed-meshheading:8101534-Terfenadine
|
pubmed:year |
1993
|
pubmed:articleTitle |
Topical levocabastine compared with orally administered terfenadine for the prophylaxis and treatment of seasonal rhinoconjunctivitis.
|
pubmed:affiliation |
Bogstadveien O-N-H Klinikk, Oslo, Norway.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Multicenter Study
|